(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 2.02% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Sanofi's revenue in 2026 is $50,740,000,000.On average, 25 Wall Street analysts forecast SNY's revenue for 2026 to be $60,600,838,785,417, with the lowest SNY revenue forecast at $56,652,317,159,571, and the highest SNY revenue forecast at $67,794,322,681,512. On average, 22 Wall Street analysts forecast SNY's revenue for 2027 to be $64,746,407,555,739, with the lowest SNY revenue forecast at $60,185,271,410,208, and the highest SNY revenue forecast at $71,675,898,803,145.
In 2028, SNY is forecast to generate $67,637,695,464,108 in revenue, with the lowest revenue forecast at $64,301,788,357,947 and the highest revenue forecast at $71,934,838,960,950.